Europe - April 2017

  • Europe: Latest timings on the new Regulations for medical devices and IVDs

  • Europe: Products whose principal intended action (depending on PAC present in cranberry) is to prevent or treat cystitis, should not be medical devices

  • Europe: Joint Action on Market Surveillance of Medical Devices launched at 39th CAMD meeting

  • Europe: Eucomed and EDMA formally merge to create MedTech Europe

  • France: Advice for French manufacturers if their Notified Bodies cease operations

  • Sweden: Responsibility for Notified Bodies to transfer to MPA from SWEDAC

  • Switzerland: Grace period for manufacturers affected by the de-designation of their Notified Body

  • UK: Significant fee increases proposed by MHRA to aid cost recovery

Click here for the full article on Global Regulatory Press.

Contact us at

Recent Posts